News | November 25, 2023
DxVx plans to make a license-in agreement of OVM-200
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
This innovative solution comes as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
PhytoSquene now available for clinical and commercial use
Aster Whitefield will be Aster's 3 rd multi-specialty hospital in Bengaluru and overall 19th hospital in India
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
Three-point improvement achieved in Sex Ratio at Birth from 904 in 2017-19 to 907 in 2018-20
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer
Subscribe To Our Newsletter & Stay Updated
